About Ultralight
Ultralight Labs focuses on improving the medical device industry by simplifying the compliance process for manufacturers and development teams. Their platform integrates requirements risk management and end-to-end traceability into a single system, making it easier for teams to collaborate and maintain compliance efficiently. Unlike competitors, Ultralight Labs offers a user-friendly and lightweight solution that accelerates innovation without compromising on speed. The company's goal is to help medical device teams streamline their workflows, enabling them to focus on developing new medical devices while ensuring they meet regulatory requirements.
New York City, New YorkHeadquarters
2022Year Founded
$2.6MTotal Funding
SEEDCompany Stage
Biotechnology, HealthcareIndustries
1-10Employees
Risks
Increased competition from established players like Greenlight Guru could impact market share.
Rapid technological advancements may necessitate frequent updates to Ultralight's platform.
Potential changes in FDA regulations could require significant platform adjustments.
Differentiation
Ultralight offers a lightweight platform optimized for modern device development.
The platform integrates risk management, traceability, and compliance in a single system.
Ultralight's user-friendly design enhances collaboration among engineering, quality, and regulatory teams.
Upsides
Growing demand for cloud-based solutions aligns with Ultralight's platform-as-a-service model.
Integration of AI in compliance management enhances proactive risk management capabilities.
Rising importance of real-time data analytics offers opportunities for advanced platform features.
Funding
Total raised$2.61 M
Latest valuation$13.40 M
StageSEED
SEED
6/30/2023$3
$13.40 M